Exagen (XGN) Competitors $5.15 +0.44 (+9.34%) (As of 12/20/2024 05:17 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends XGN vs. AIRS, VMD, SERA, PSNL, LFMD, BDSX, QIPT, EUDA, BNR, and PIIIShould you be buying Exagen stock or one of its competitors? The main competitors of Exagen include AirSculpt Technologies (AIRS), Viemed Healthcare (VMD), Sera Prognostics (SERA), Personalis (PSNL), LifeMD (LFMD), Biodesix (BDSX), Quipt Home Medical (QIPT), EUDA Health (EUDA), Burning Rock Biotech (BNR), and P3 Health Partners (PIII). These companies are all part of the "healthcare" industry. Exagen vs. AirSculpt Technologies Viemed Healthcare Sera Prognostics Personalis LifeMD Biodesix Quipt Home Medical EUDA Health Burning Rock Biotech P3 Health Partners Exagen (NASDAQ:XGN) and AirSculpt Technologies (NASDAQ:AIRS) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, community ranking, analyst recommendations, valuation, institutional ownership, media sentiment, dividends and profitability. Is XGN or AIRS more profitable? AirSculpt Technologies has a net margin of -4.13% compared to Exagen's net margin of -30.36%. AirSculpt Technologies' return on equity of 2.22% beat Exagen's return on equity.Company Net Margins Return on Equity Return on Assets Exagen-30.36% -92.58% -33.74% AirSculpt Technologies -4.13%2.22%0.90% Do institutionals and insiders hold more shares of XGN or AIRS? 75.3% of Exagen shares are held by institutional investors. Comparatively, 91.5% of AirSculpt Technologies shares are held by institutional investors. 26.1% of Exagen shares are held by insiders. Comparatively, 78.8% of AirSculpt Technologies shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has more volatility & risk, XGN or AIRS? Exagen has a beta of 1.49, meaning that its stock price is 49% more volatile than the S&P 500. Comparatively, AirSculpt Technologies has a beta of 1.64, meaning that its stock price is 64% more volatile than the S&P 500. Does the media prefer XGN or AIRS? In the previous week, AirSculpt Technologies had 5 more articles in the media than Exagen. MarketBeat recorded 5 mentions for AirSculpt Technologies and 0 mentions for Exagen. AirSculpt Technologies' average media sentiment score of 0.49 beat Exagen's score of 0.00 indicating that AirSculpt Technologies is being referred to more favorably in the news media. Company Overall Sentiment Exagen Neutral AirSculpt Technologies Neutral Does the MarketBeat Community favor XGN or AIRS? Exagen received 10 more outperform votes than AirSculpt Technologies when rated by MarketBeat users. Likewise, 55.26% of users gave Exagen an outperform vote while only 39.29% of users gave AirSculpt Technologies an outperform vote. CompanyUnderperformOutperformExagenOutperform Votes2155.26% Underperform Votes1744.74% AirSculpt TechnologiesOutperform Votes1139.29% Underperform Votes1760.71% Which has better earnings and valuation, XGN or AIRS? AirSculpt Technologies has higher revenue and earnings than Exagen. AirSculpt Technologies is trading at a lower price-to-earnings ratio than Exagen, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioExagen$55.75M1.63-$23.69M-$0.94-5.48AirSculpt Technologies$188.78M1.64-$4.48M-$0.14-38.21 Do analysts recommend XGN or AIRS? Exagen presently has a consensus price target of $7.00, suggesting a potential upside of 35.92%. AirSculpt Technologies has a consensus price target of $5.00, suggesting a potential downside of 6.54%. Given Exagen's stronger consensus rating and higher possible upside, equities analysts clearly believe Exagen is more favorable than AirSculpt Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Exagen 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00AirSculpt Technologies 0 Sell rating(s) 4 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 SummaryAirSculpt Technologies beats Exagen on 12 of the 18 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Get Exagen News Delivered to You Automatically Sign up to receive the latest news and ratings for XGN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart XGN vs. The Competition Export to ExcelMetricExagenMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$90.83M$2.93B$5.13B$9.07BDividend YieldN/A15.63%5.08%4.23%P/E Ratio-5.4816.0289.7417.18Price / Sales1.63284.461,116.12116.95Price / CashN/A472.1142.8237.86Price / Book3.875.194.774.78Net Income-$23.69M-$32.86M$120.15M$225.60M7 Day Performance-10.82%-3.01%-1.92%-1.23%1 Month Performance31.60%2.96%11.47%3.36%1 Year Performance197.69%12.37%30.52%16.60% Exagen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)XGNExagen4.6627 of 5 stars$5.15+9.3%$7.00+35.9%+191.0%$90.83M$55.75M-5.48220AIRSAirSculpt Technologies0.3584 of 5 stars$6.04+6.3%$5.00-17.2%-26.3%$349.61M$188.78M-43.71346Positive NewsVMDViemed Healthcare1.7209 of 5 stars$8.68-0.7%N/A+3.6%$338.00M$183.01M32.37630Positive NewsSERASera Prognostics0.2236 of 5 stars$8.29-3.8%N/A+28.2%$279.95M$310,000.00-8.71120News CoveragePSNLPersonalis3.9711 of 5 stars$3.78-1.0%$6.81+80.2%+293.8%$267.06M$73.48M-2.27400Analyst ForecastNews CoverageGap UpLFMDLifeMD1.4002 of 5 stars$5.84+2.6%$11.57+98.1%-37.0%$252.94M$193.06M-8.89230Positive NewsBDSXBiodesix2.5565 of 5 stars$1.36+1.5%$3.06+125.0%-4.8%$197.84M$65.56M-3.44220QIPTQuipt Home Medical2.5539 of 5 stars$3.13+4.0%$6.25+99.7%-49.5%$134.87M$221.74M-27.361,200Earnings ReportAnalyst RevisionNews CoveragePositive NewsGap UpEUDAEUDA Health0.3174 of 5 stars$5.35-10.2%N/A+246.2%$131.76M$3.81M0.002BNRBurning Rock Biotech1.9789 of 5 stars$6.75+0.3%N/A-12.3%$69.15M$510.89M-2.241,390Positive NewsPIIIP3 Health Partners2.3841 of 5 stars$0.19-7.3%$2.38+1,150.0%-83.0%$68.18M$1.48B-0.24500News Coverage Related Companies and Tools Related Companies AIRS Alternatives VMD Alternatives SERA Alternatives PSNL Alternatives LFMD Alternatives BDSX Alternatives QIPT Alternatives EUDA Alternatives BNR Alternatives PIII Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:XGN) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exagen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Exagen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free XGN Stock Alerts